Saturday, December 6, 2025

Biosimilars No Longer Second-Best: Highlighting Cost Savings and Improved Patient Access

Biosimilars are becoming standard care, with growing confidence in their safety and efficacy, driven by cost savings and improved accessibility.

Chaos on the Field: Euro 2024 Plagued by Safety Issues and Fan Misconduct

The UEFA European Football Championship (Euro) 2024...

Korea Transportation Safety Authority Enhances Bus Safety With AI Image Technology

The Korea Transportation Safety Authority (TS) announced...

Tag: Moon Jae In

No posts to display

Top News

- Our Sponsors Ad -

Follow us